Bright key facts / Emerging

GSK expands Chai collaboration after testing AI-designed proteins

A reported laboratory evaluation offers an early look at how computer-designed molecules could enter drug research.

AI’s role
AI proposes protein designs for laboratory testing.
Documented result
GSK’s experiments found molecules that bound to every target tested.
Important limitation
The release does not disclose how many targets or designs were tested, detailed methods or numerical success rates.

Source published 2026-10-09 · Bright published 2026-10-09 · Evidence and limitations

Bright AI Future · No tracking scripts in this embed.